Intracranial infections are the most serious and common postoperative complications with significant mortality and morbidity. Myroides odoratimimus (M. odoratimimus), a Gram-negative environmental species and an opportunistic microorganism, predominantly infects immunocompromised individuals. Limited clinical experiences and documented multidrug resistance have resulted in a scarcity of data on the treatment of M. odoratimimus infections. As far as we know, this is the first reported case of an intracranial M. odoratimimus infection with external ventricular drains (EVD) that was effectively treated with a combination of intravenous and intraventricular tigecycline in an immunocompetent adult host.
CITATION STYLE
Jiang, L. Z., Shen, Y., Liang, F., Ye, X. M., Chen, J., & Yu, Y. M. (2023). Intracranial Myroides odoratimimus Infection After EVD Successfully Treated with Intravenous Plus Intraventricular Tigecycline: A Case Report. Infection and Drug Resistance, 16, 1955–1963. https://doi.org/10.2147/IDR.S403088
Mendeley helps you to discover research relevant for your work.